Given the pivotal role of ATGL in lipid metabolism and glycolysis as a strategy for rapid ATP synthesis with less ROS in cancer cells [35], a possible contribution of ATGL downregulation to the switch from mitochondrial metabolism to a glycolytic phenotype was investigated. The gene discussed is PNPLA2; the disease is cancer.